2020 FDA drug approvals
Publication type: Journal Article
Publication date: 2021-01-05
scimago Q1
wos Q1
SJR: 30.506
CiteScore: 181.8
Impact factor: 101.8
ISSN: 14741776, 14741784
PubMed ID:
33402709
Drug Discovery
General Medicine
Pharmacology
Abstract
The FDA approved 53 novel drugs in 2020, the second highest count in over 20 years. The FDA approved 53 novel drugs in 2020, the second highest count in over 20 years.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Journal of Medicinal Chemistry
5 publications, 2.98%
|
|
|
Pharmaceutics
4 publications, 2.38%
|
|
|
European Journal of Medicinal Chemistry
4 publications, 2.38%
|
|
|
International Journal of Pharmaceutics
4 publications, 2.38%
|
|
|
BMC Bioinformatics
3 publications, 1.79%
|
|
|
ACS applied materials & interfaces
2 publications, 1.19%
|
|
|
International Journal of Toxicology
2 publications, 1.19%
|
|
|
Pharmaceuticals
2 publications, 1.19%
|
|
|
Molecules
2 publications, 1.19%
|
|
|
Frontiers in Pharmacology
2 publications, 1.19%
|
|
|
Naunyn-Schmiedeberg's Archives of Pharmacology
2 publications, 1.19%
|
|
|
Nature Reviews Drug Discovery
2 publications, 1.19%
|
|
|
Journal of Solution Chemistry
2 publications, 1.19%
|
|
|
Drug Discovery Today
2 publications, 1.19%
|
|
|
Colloids and Surfaces B: Biointerfaces
2 publications, 1.19%
|
|
|
Journal of Controlled Release
2 publications, 1.19%
|
|
|
ACS Omega
2 publications, 1.19%
|
|
|
Briefings in Bioinformatics
2 publications, 1.19%
|
|
|
Scientific Reports
2 publications, 1.19%
|
|
|
Nature Communications
2 publications, 1.19%
|
|
|
Angewandte Chemie - International Edition
2 publications, 1.19%
|
|
|
Angewandte Chemie
2 publications, 1.19%
|
|
|
Pharmacological Reviews
1 publication, 0.6%
|
|
|
Emerging Topics in Life Sciences
1 publication, 0.6%
|
|
|
Bioanalysis
1 publication, 0.6%
|
|
|
Health Affairs
1 publication, 0.6%
|
|
|
Cancers
1 publication, 0.6%
|
|
|
Nanomaterials
1 publication, 0.6%
|
|
|
Life
1 publication, 0.6%
|
|
|
1
2
3
4
5
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
42 publications, 25%
|
|
|
Springer Nature
33 publications, 19.64%
|
|
|
American Chemical Society (ACS)
17 publications, 10.12%
|
|
|
Wiley
17 publications, 10.12%
|
|
|
MDPI
14 publications, 8.33%
|
|
|
Taylor & Francis
5 publications, 2.98%
|
|
|
Frontiers Media S.A.
5 publications, 2.98%
|
|
|
Oxford University Press
5 publications, 2.98%
|
|
|
SAGE
3 publications, 1.79%
|
|
|
Royal Society of Chemistry (RSC)
3 publications, 1.79%
|
|
|
American Medical Association (AMA)
2 publications, 1.19%
|
|
|
Cold Spring Harbor Laboratory
2 publications, 1.19%
|
|
|
Bentham Science Publishers Ltd.
2 publications, 1.19%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.6%
|
|
|
Portland Press
1 publication, 0.6%
|
|
|
Health Affairs (Project Hope)
1 publication, 0.6%
|
|
|
BMJ
1 publication, 0.6%
|
|
|
Annual Reviews
1 publication, 0.6%
|
|
|
S. Karger AG
1 publication, 0.6%
|
|
|
SPIE-Intl Soc Optical Eng
1 publication, 0.6%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.6%
|
|
|
SPb RAACI
1 publication, 0.6%
|
|
|
Georg Thieme Verlag KG
1 publication, 0.6%
|
|
|
IMR Press
1 publication, 0.6%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 0.6%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
168
Total citations:
168
Citations from 2024:
39
(23.21%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
RIS
Copy
TY - JOUR
DO - 10.1038/d41573-021-00002-0
UR - https://doi.org/10.1038/d41573-021-00002-0
TI - 2020 FDA drug approvals
T2 - Nature Reviews Drug Discovery
AU - Mullard, Asher
PY - 2021
DA - 2021/01/05
PB - Springer Nature
SP - 85-90
IS - 2
VL - 20
PMID - 33402709
SN - 1474-1776
SN - 1474-1784
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Mullard,
author = {Asher Mullard},
title = {2020 FDA drug approvals},
journal = {Nature Reviews Drug Discovery},
year = {2021},
volume = {20},
publisher = {Springer Nature},
month = {jan},
url = {https://doi.org/10.1038/d41573-021-00002-0},
number = {2},
pages = {85--90},
doi = {10.1038/d41573-021-00002-0}
}
Cite this
MLA
Copy
Mullard, Asher. “2020 FDA drug approvals.” Nature Reviews Drug Discovery, vol. 20, no. 2, Jan. 2021, pp. 85-90. https://doi.org/10.1038/d41573-021-00002-0.